- Home
- LNTH vs GGAL Comparison
LNTH vs GGAL Comparison
Compare LNTH & GGAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- GGAL
- Stock Information
- Founded
- LNTH 1956
- GGAL 1905
- Country
- LNTH United States
- GGAL Argentina
- Employees
- LNTH N/A
- GGAL 12440
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- GGAL Commercial Banks
- Sector
- LNTH Health Care
- GGAL Finance
- Exchange
- LNTH Nasdaq
- GGAL Nasdaq
- Market Cap
- LNTH 7.5B
- GGAL 9.4B
- IPO Year
- LNTH 2015
- GGAL N/A
- Fundamental
- Price
- LNTH $78.81
- GGAL $62.71
- Analyst Decision
- LNTH Strong Buy
- GGAL Strong Buy
- Analyst Count
- LNTH 5
- GGAL 4
- Target Price
- LNTH $133.80
- GGAL $59.00
- AVG Volume (30 Days)
- LNTH 1.3M
- GGAL 1.1M
- Earning Date
- LNTH 05-07-2025
- GGAL 01-01-0001
- Dividend Yield
- LNTH N/A
- GGAL 3.80%
- EPS Growth
- LNTH N/A
- GGAL 120.03
- EPS
- LNTH 3.53
- GGAL 1.06
- Revenue
- LNTH $1,536,699,000.00
- GGAL $6,697,505,438.00
- Revenue This Year
- LNTH $5.81
- GGAL $11.73
- Revenue Next Year
- LNTH $12.26
- GGAL N/A
- P/E Ratio
- LNTH $22.33
- GGAL $6.63
- Revenue Growth
- LNTH 12.53
- GGAL N/A
- 52 Week Low
- LNTH $74.34
- GGAL $23.53
- 52 Week High
- LNTH $126.89
- GGAL $74.00
- Technical
- Relative Strength Index (RSI)
- LNTH 27.83
- GGAL 59.78
- Support Level
- LNTH $78.61
- GGAL $57.11
- Resistance Level
- LNTH $83.60
- GGAL $63.69
- Average True Range (ATR)
- LNTH 3.82
- GGAL 2.34
- MACD
- LNTH -2.99
- GGAL 0.16
- Stochastic Oscillator
- LNTH 5.64
- GGAL 74.71
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About GGAL Grupo Financiero Galicia S.A.
Grupo Financiero Galicia SA is a financial service holding company. It provides general banking services, proprietary brand credit card services, personal loans, insurance, and other services. The company's operating business segments are Banks, Ecosistema Naranja X, Insurance, Adjustments, and Other Businesses. It generates maximum revenue from Banks. Geographically its operate in Argentina, Uruguay, and the majority of its revenue comes from Argentina.